In Reply
- PMID: 28855051
- PMCID: PMC5596155
- DOI: 10.3238/arztebl.2017.0560b
In Reply
Comment on
-
Rheumatic Heart Disease Still Relevant.Dtsch Arztebl Int. 2017 Aug 21;114(33-34):559. doi: 10.3238/arztebl.2017.0559a. Dtsch Arztebl Int. 2017. PMID: 28855048 Free PMC article. No abstract available.
-
Cardioprotective Effect of NSAIDs.Dtsch Arztebl Int. 2017 Aug 21;114(33-34):559. doi: 10.3238/arztebl.2017.0559b. Dtsch Arztebl Int. 2017. PMID: 28855049 Free PMC article. No abstract available.
-
Cardiovascular Comorbidities.Dtsch Arztebl Int. 2017 Aug 21;114(33-34):560. doi: 10.3238/arztebl.2017.0560a. Dtsch Arztebl Int. 2017. PMID: 28855050 Free PMC article. No abstract available.
References
-
- Mihaylova B, Emberson J, Blackwell L, et al. Cholesterol Treatment Trialists‘ (CTT) Collaborators The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581–590. - PMC - PubMed
-
- Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A. Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine. 2011;78:179–183. - PubMed
-
- McCarey DW, McInnes IB, Madhok R, et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet. 2004;363:2015–2021. - PubMed
Publication types
LinkOut - more resources
Full Text Sources